Chunrui Li

18PUBLICATIONS

65CO-AUTHORS

ClinimetricsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Jun 23, 2026

A Multicenter National Study of AL Amyloidosis in China: Insights Into Real-World Diagnosis, Treatment, and Prognosis.

|Mar 27, 2026

Dynamic Targetable Extracellular Vesicle Surface Proteins Monitor Depth of Response to CAR T Therapy.

Chen Zhao, Lei Qiu, Ning An

|Mar 26, 2026

In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study.

Ning An, Di Wang, Peiling Zhang

|Oct 24, 2025

Long-term Therapy Outcomes of CD19/22 CAR T Cell Alone or with Autologous Stem Cell Transplantation for Relapsed/Refractory DLBCL.

Xiaoying Zhang, Jue Wang, Na Wang

|Jun 03, 2025

Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study.

Sikander Ailawadhi, Ivan Špička, Andrew Spencer

|May 22, 2025

Harnessing Cellular Immunotherapy for EBV-Associated Malignancies: Current Advances and Future Directions.

Yang Gao, Di Wang, Chunrui Li

Pageof 3

Frequent Collaborators

Liang Huang

Wen Wang

Jianfeng Zhou

Jue Wang

Qinglei Gao

Peiling Zhang

Yi Xiao

Jia Wei

Chuan Qin

Ming-Hao Dong

Frequent Collaborators

Liang Huang

Wen Wang

Jianfeng Zhou

Jue Wang